World Hashish Firm Expands Provide Chain in Europe via Settlement with Full Hemp Applied sciences
SAN DIEGO, CA, Sept. 08, 2022 (GLOBE NEWSWIRE) — by way of NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Firm”), the first-ever publicly traded hashish firm in america that launched the world’s first-ever cannabis-derived nutraceutical merchandise, manufacturers, and provide chain, introduced right this moment that its subsidiary, Kannaway, has signed a distribution settlement with long-time companion Full Hemp Applied sciences (CHT) to broaden its capabilities within the European market. The settlement provides warehousing and every day operations to the providers that CHT already offers to Kannaway in Europe, offering cost-savings and gross margins enhancements in one of many Firm’s largest worldwide markets.
The Firm has labored with CHT for years to facilitate growth all through Europe, leveraging their sturdy relationships with regulators and trade main hashish primarily based product capabilities. CHT will even now present distribution providers eliminating the necessity to transport product after manufacture in addition to fund further warehouse area and related labor prices.
“As the primary US firm to enter Europe with our hemp-based merchandise, now we have constructed long-standing relationships with the area’s most educated firms and this settlement is an ideal instance of that,” mentioned Medical Marijuana, Inc. CEO Blake Schroeder. “It’s a win-win for each firms. We’ll proceed to leverage our superior product formulations and model fairness as the unique trusted supply for high quality merchandise, whereas being supported by a good firm with a confirmed observe file of success.”
“We’re pleased to proceed to work with Medical Marijuana, Inc. and its household of firms,” mentioned Rafal Modlinski, CEO of Full Hemp Applied sciences. “Their dedication to creating high quality merchandise and distributing them on a world foundation totally aligns with our imaginative and prescient right here at CHT. By way of this settlement we will broaden each our attain and the attain of Medical Marijuana, Inc. and Kannaway merchandise.”
ABOUT MEDICAL MARIJUANA, INC.:
We’re an organization of firsts®. Medical Marijuana, Inc. (MJNA) is a hashish firm with three distinct enterprise models within the non-psychoactive cannabinoid area: a world portfolio of cannabinoid-based nutraceutical manufacturers led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality authorized non-psychoactive hashish merchandise derived from industrial hemp; and a cannabinoid-based scientific analysis and botanical drug growth sector led by its pharmaceutical funding firms and companions together with AXIM® Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. was named a prime CBD producer by CNBC. Medical Marijuana, Inc. was additionally the primary firm to obtain historic import permits for CBD merchandise from the governments of Brazil, Mexico, Argentina, and Paraguay and is a frontrunner within the growth of worldwide markets. The corporate’s flagship product Actual Scientific Hemp Oil has been utilized in a number of profitable scientific research all through Mexico and Brazil to know its security and efficacy.
Medical Marijuana, Inc.’s headquarters is in San Diego, California, and extra info is accessible at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s company video, click on right here.
FORWARD-LOOKING DISCLAIMER:
This press launch could include sure forward-looking statements and data, as outlined throughout the that means of Part 27A of the Securities Act of 1933 and Part 21E of the Securities Change Act of 1934, and is topic to the Protected Harbor created by these sections. This materials incorporates statements about anticipated future occasions and/or monetary outcomes which are forward-looking in nature and topic to dangers and uncertainties. Such forward-looking statements by definition contain dangers, uncertainties and different components, which can trigger the precise outcomes, efficiency or achievements of Medical Marijuana, Inc. to be materially completely different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE:
These statements haven’t been evaluated by the Meals and Drug Administration. This product shouldn’t be supposed to diagnose, deal with, treatment, or forestall any illness.
LEGAL DISCLOSURE:
Medical Marijuana, Inc. doesn’t promote or distribute any merchandise which are in violation of america Managed Substances Act.
CONTACT:
Public Relations Contact:
Kyle Porter
CEO
CMW Media
P. 858-221-8001
[email protected]
www.cmwmedia.com
Investor Relations Contact:
P. (858) 283-4016
[email protected]
